Search research articles
Contact Us
Filters
Showing results (31-40 of 49) with videos related to
Page
of 5
Sort By:
Molecular Psychiatry
|
May 24, 2000
Muscarinic1 and 2 receptor mRNA in the human caudate-putamen: no change in m1 mRNA in schizophrenia
B Dean, J M Crook, G Pavey, et al.
Urology
|
May 20, 1998
Serum prostate-specific antigen profile following radiotherapy for prostate cancer: implications for patterns of failure and definition of cure
J M Crook, E Choan, G A Perry, et al.
Experimental Brain Research
|
January 1, 1991
The neurophysiological correlates of colour and brightness contrast in lateral geniculate neurons. I. Population analysis
O D Creutzfeldt, J M Crook, S Kastner, et al.
Molecular Psychiatry
|
March 1, 1996
The density of muscarinic M1 receptors is decreased in the caudate-putamen of subjects with schizophrenia
B Dean, J M Crook, K Opeskin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 1, 1987
Dose-volume analysis and the prevention of radiation sequelae in cervical cancer
J M Crook, B A Esche, G Chaplain, et al.
Molecular Psychiatry
|
February 13, 2002
Comparative analysis of group II metabotropic glutamate receptor immunoreactivity in Brodmann's area 46 of the dorsolateral prefrontal cortex from patients with schizophrenia and normal subjects
J M Crook, M Akil, B C W Law, et al.
Cancer
|
January 1, 1997
Evaluation of radiation effect, tumor differentiation, and prostate specific antigen staining in sequential prostate biopsies after external beam radiotherapy for patients with prostate carcinoma
J M Crook, Y A Bahadur, S J Robertson, et al.
Cancer
|
January 15, 1997
Radiotherapy for localized prostate carcinoma. The correlation of pretreatment prostate specific antigen and nadir prostate specific antigen with outcome as assessed by systematic biopsy and serum prostate specific antigen
J M Crook, Y A Bahadur, R G Bociek, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 1, 1990
Interstitial iridium 192 for cutaneous carcinoma of the external nose
J M Crook, J J Mazeron, G Marinello, et al.
Molecular Psychiatry
|
December 17, 2009
Modelling disrupted-in-schizophrenia 1 loss of function in human neural progenitor cells: tools for molecular studies of human neurodevelopment and neuropsychiatric disorders
N R Kobayashi, L Sui, P S L Tan, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 49) with videos related to
Sort By:
Page
of 5
Molecular Psychiatry
|
May 24, 2000
Muscarinic1 and 2 receptor mRNA in the human caudate-putamen: no change in m1 mRNA in schizophrenia
B Dean, J M Crook, G Pavey, et al.
Urology
|
May 20, 1998
Serum prostate-specific antigen profile following radiotherapy for prostate cancer: implications for patterns of failure and definition of cure
J M Crook, E Choan, G A Perry, et al.
Experimental Brain Research
|
January 1, 1991
The neurophysiological correlates of colour and brightness contrast in lateral geniculate neurons. I. Population analysis
O D Creutzfeldt, J M Crook, S Kastner, et al.
Molecular Psychiatry
|
March 1, 1996
The density of muscarinic M1 receptors is decreased in the caudate-putamen of subjects with schizophrenia
B Dean, J M Crook, K Opeskin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 1, 1987
Dose-volume analysis and the prevention of radiation sequelae in cervical cancer
J M Crook, B A Esche, G Chaplain, et al.
Molecular Psychiatry
|
February 13, 2002
Comparative analysis of group II metabotropic glutamate receptor immunoreactivity in Brodmann's area 46 of the dorsolateral prefrontal cortex from patients with schizophrenia and normal subjects
J M Crook, M Akil, B C W Law, et al.
Cancer
|
January 1, 1997
Evaluation of radiation effect, tumor differentiation, and prostate specific antigen staining in sequential prostate biopsies after external beam radiotherapy for patients with prostate carcinoma
J M Crook, Y A Bahadur, S J Robertson, et al.
Cancer
|
January 15, 1997
Radiotherapy for localized prostate carcinoma. The correlation of pretreatment prostate specific antigen and nadir prostate specific antigen with outcome as assessed by systematic biopsy and serum prostate specific antigen
J M Crook, Y A Bahadur, R G Bociek, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 1, 1990
Interstitial iridium 192 for cutaneous carcinoma of the external nose
J M Crook, J J Mazeron, G Marinello, et al.
Molecular Psychiatry
|
December 17, 2009
Modelling disrupted-in-schizophrenia 1 loss of function in human neural progenitor cells: tools for molecular studies of human neurodevelopment and neuropsychiatric disorders
N R Kobayashi, L Sui, P S L Tan, et al.
Page
of 5